Auro Laboratories Limited has submitted the Audited Financial Results for the quarter and year ended March 31 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Auro Laboratories Limited has reported its audited financial results for the quarter and year ended March 31, 2025. Full-year revenue from operations fell sharply to ₹1,939.84 lakhs from ₹5,363.52 lakhs in FY24, while profit after tax dropped to ₹183.88 lakhs from ₹779.21 lakhs. Q4 FY25 revenue was ₹740 lakhs versus ₹1,206.29 lakhs in Q4 FY24, with Q4 profit at ₹39.42 lakhs (down from ₹232.05 lakhs). The Board approved the appointment of Mr. Kuntal Pancholi as the new Chief Financial Officer and Key Managerial Personnel effective May 30, 2025, and M/s. Pokharna and Associates as Internal Auditors for FY 2025-26. Statutory Auditors Kothari Jain & Associates issued an unmodified (clean) opinion on the results.
The sharp year-on-year decline in both revenue and profitability is a red flag for shareholders, although ongoing capital expenditure (capital work-in-progress nearly doubled) suggests management is investing for future capacity. The mid-year CFO changeover, combined with rising borrowings (from ₹1,838 lakhs to ₹3,309 lakhs), points to a period of transition that investors should watch closely.